pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Cobenfy · news · pharmadog
← back to Cobenfy
News mentioning Cobenfy
10
stories
2d
Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs
biopharma dive
3d
BMS’ ‘big beat’ clouded by Cobenfy, heart disease data delays
biospace
4d
Bristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat
fiercebiotech
4d
MapLight CEO on what investors missed in the biotech’s schizophrenia data
biopharma dive
6d
MapLight dives despite positive data for schizophrenia drug
biopharma dive
6d
MapLight’s schizophrenia pill remains in Cobenfy’s shadow after mixed Phase 2 readout
biospace
7d
MapLight shares sink on mixed phase 2 schizophrenia readout
fiercebiotech
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
May 1, 26
Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook
biopharma dive
Apr 28, 26
Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.
biopharma dive
